On this episode of the Business of Biotech, we’re going deep with Glympse Bio President & CEO Dr. Caroline Loew to explore the possibilities and implications of the in-vivo, bioengineered, tunable sensors the company is developing for diagnostic and prognostic purposes in protease-mediates diseases. Currently in the clinic with applications for Non-Alcoholic Steatohepatitis and other […]

DarioHealth (NSDQ:DRIO) announced today that recently published research supports its digital therapeutic platform for type 2 diabetes. New York-based DarioHealth published a new study through a letter to the editor in the Journal of Diabetes Science and Technology, according to a news release. The study observed participants using DarioHealth’s digital therapeutics for diabetes management, monitoring […]

Another digital health company is looking to make the link between physical and mental health conditions. DarioHealth, a company that provides a smartphone-based system to help people monitor their blood sugar levels, recently struck an agreement to buy mental health startup WayForward for $25 million. Combined with DarioHealth’s other programs for diabetes, hypertension and back […]